nach oben

The Patient - Patient-Centered Outcomes Research

Erschienen in:

01.12.2016 | Editorial

Using PROMs in Healthcare: Who Should Be in the Driving Seat—Policy Makers, Health Professionals, Methodologists or Patients?

verfasst von: Kirstie L. Haywood, Roger Wilson, Sophie Staniszewska, Sam Salek

Erschienen in: The Patient - Patient-Centered Outcomes Research | Ausgabe 6/2016

Einloggen, um Zugang zu erhalten

Excerpt

The recent Cancer Strategy for England (2016) highlights that by March 2017 NHS England will have agreed an approach for data collection which includes patient-reported outcome measures (PROMs) as a means for assessing long-term quality of life (QoL) for cancer patients [1]. Moreover, it indicates that “people affected by cancer (and clinical leaders) … will be in the driving seat for improving quality across cancer pathways” ([1] p. 18). …

Achieving World-Class Cancer Outcomes: Taking the strategy forward. Five Year Forward View. 2016. https://www.england.nhs.uk/wp-content/uploads/2016/05/cancer-strategy.pdf. Accessed 28 July 2016.

ReseArch with Patient and Pulich involvement: a RealisT evaluation—the RAPPORT study. Health Services and Delivery Research, vol 3, Issue 38. 2015. ISSN 2050-4349. http://www.journalslibrary.nihr.ac.uk/__data/assets/pdf_file/0009/152298/FullReport-hsdr03380.pdf.

Whitehead L, Perkins GD, Clarey A, Haywood KL. A systematic review of the outcomes reported in cardiac arrest clinical trials: the need for a core outcome set. Resuscitation. 2015;88:150–7.

Hewlett SA. Patients and clinicians have different perspectives on outcomes in arthritis. J Rheumatol. 2003;30(4):877–9.

Staniszewska S, Haywood KL, Brett J, Tutton L. Patient and public involvement in patient-reported outcome measures: evolution not revolution. Patient. 2012;5(2):79–87.CrossRefPubMed

Gough NJ, Smith C, Ross JR, Riley J, Judson I. Symptom burden, survival and palliative care in advanced soft tissue sarcoma. Sarcoma. 2011;2011. Article ID 325189 (Epub Dec 2011).

Williamson PR, Altman DG, Blazeby JM, Clarke M, Devane D, Gargon E, Tugwell P. Developing core outcome sets for clinical trials: issues to consider. Trials. 2012;13:132.

Schmitt J, Langan S, Stamm T, Williams HC; Harmonizing Outcome Measurements in Eczema (HOME) Delphi panel. Core outcome domains for controlled trials and clinical recordkeeping in eczema: international multiperspective Delphi consensus process. J Invest Dermatol. 2011;131(3):623–30.

Haywood KL, Whitehead L, Perkins GD. The psychosocial outcomes of cardiac arrest: relevant and robust patient-centred assessment is essential. Resuscitation. 2014;85(6):718.

10.

Murdoch TB, Detsky AS. The inevitable application of big data to health care. JAMA. 2013;309(13):1351–2.CrossRefPubMed

11.

Wilson R. Use MY data mini blog. 2016. http://www.usemydata.org/blog1.shtml. Accessed 28 July 2016.

12.

Kirkham JJ, Dwan KM, Altman DG, Gamble C, Dodd S, Smyth R, Williamson PR. The impact of outcome reporting bias in randomised controlled trials on a cohort of systematic reviews. BMJ. 2010;340:c365.

13.

Smith V, Clarke M, Williamson P, Gargon E. Survey of new 2007 and 2011 Cochrane reviews found 37 % of prespecified outcomes not reported. J Clin Epidemiol. 2015;68(3):237–45.

14.

Huber M, Knottnerus JA, Green L, van der Horst H, Jadad AR, Kromhout D, Leonard B, Lorig K, Loureiro MI, van der Meer JW, Schnabel P, Smith R, van Weel C, Smid H. How should we define health? BMJ. 2011;343:d4163.

15.

Garratt A, Schmidt L, Mackintosh A, Fitzpatrick R. Quality of life measurement: bibliographic study of patient assessed health outcome measures. BMJ. 2002; 324(7351):1417.

16.

Haywood KL, Staniszewska S, Chapman S. Quality and acceptability of patient-reported outcome measures used in chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME): a systematic review. Qual Life Res. 2012;21(1):35–52.

17.

EuroQoL Group. EuroQol—a new facility for the measurement of health-related quality of life. Health Policy. 1990;16(3):199–208. http://www.euroqol.org/about-eq-5d.html. Accessed 28 July 2016.

18.

National Institute for Health and Care Excellence (NICE). Guide to the methods of technology appraisal 2013. Process and methods guides. London: National Institute of Health and Clinical Excellence. 2013. https://www.nice.org.uk/article/pmg9/resources/non-guidance-guide-to-the-methods-of-technology-appraisal-2013-pdf. Accessed 28 July 2016.

19.

Longworth L, Yang Y, Young T. Use of generic and condition-specific measures of health-related quality of life in NICE decision-making: a systematic review, statistical modelling and survey. Health Technol Assess. 2014;18(9). ISSN 1366-5278.

20.

Devlin N, Appleby J. Getting the Most Out of PROMs. Putting health outcomes at the heart of NHS decision-making. The Kings Fund, London. 2010. https://www.kingsfund.org.uk/sites/files/kf/Getting-the-most-out-of-PROMs-Nancy-Devlin-John-Appleby-Kings-Fund-March-2010.pdf. Accessed 28 July 2016.

21.

Hobart JC, Cano SJ, Zajicek JP, Thompson AJ. Rating scales as outcome measures for clinical trials in neurology: problems, solutions, and recommendations. Lancet Neurol. 2007;6:1094–105.CrossRefPubMed

22.

de Wit M, Abma T, Koelewijn-van Loon M, Collins S, Kirwan J. Involving patient research partners has a significant impact on outcomes research: a responsive evaluation of the international OMERACT conferences. BMJ Open. 2013;3(5) (pii: e002241).

23.

Gossec L, de Wit M, Kiltz U, Braun J, Kalyoncu U, Scrivo R, Maccarone M, Carton L, Otsa K, Sooäär I, Heiberg T, Bertheussen H, Cañete JD, Sánchez Lombarte A, Balanescu A, Dinte A, de Vlam K, Smolen JS, Stamm T, Niedermayer D, Békés G, Veale D, Helliwell P, Parkinson A, Luger T, Kvien TK; EULAR PsAID Taskforce. A patient-derived and patient-reported outcome measure for assessing psoriatic arthritis: elaboration and preliminary validation of the Psoriatic Arthritis Impact of Disease (PsAID) questionnaire, a 13-country EULAR initiative. Ann Rheum Dis. 2014;73(6):1012–9.

24.

US Food and Drug Administration Guidance for Industry: Patient-Reported Outcome Measures: Use in Medical Product Development to Support Labeling Claims. Rockville: Department of Health and Human Services, Food and Drug Administration, Centre for Drug Evaluation and Research; 2009.

25.

Patrick DL, Burke LB, Gwaltney CJ, Leidy NK, Martin ML, Molsen E, Ring L. Content validity–establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO good research practices task force report: part 1–eliciting concepts for a new PRO instrument. Value Health. 2011;14(8):967–77.

26.

de Wit MP, Kvien TK, Gossec L. Patient participation as an integral part of patient-reported outcomes development ensures the representation of the patient voice: a case study from the field of rheumatology. RMD Open. 2015;1(1):e000129.

27.

Cheung PP, de Wit M, Bingham CO 3rd, Kirwan JR, Leong A, March LM, Montie P, Scholte-Voshaar M, Gossec L. Recommendations for the Involvement of Patient Research Partners (PRP) in OMERACT Working Groups. A Report from the OMERACT 2014 Working Group on PRP. J Rheumatol. 2016;43(1):187–93.

28.

Tillett W, Adebajo A, Brooke M, Campbell W, Coates LC, FitzGerald O, Gossec L, Helliwell P, Hewlett S, James J, Minnock P, Reast A, O’Sullivan D, de Wit M, McHugh N. Patient involvement in outcome measures for psoriatic arthritis. Curr Rheumatol Rep. 2014;16(5):418.

29.

Frank L, Forsythe L, Ellis L, Schrandt S, Sheridan S, Gerson J, Konopka K, Daugherty S. Conceptual and practical foundations of patient engagement in research at the patient-centred outcomes research institute. QLRes. 2015;24:1033–41.

30.

Stewart D, Wilson R, Selby P, Darbyshire J. Patient and public involvement. Ann Oncol. 2011;22(Suppl 7):vii54–56.

31.

de Vet HC, Terwee CB, Ostelo RW, Beckerman H, Knol DL, Bouter LM. Minimal changes in health status questionnaires: distinction between minimally detectable change and minimally important change. Health Qual Life Outcomes. 2006;4:54.

32.

de Vet HCW, Terwee CB, Mokkink L, Knol D. Measurement in medicine: a practical guide (Practical Guides to Biostatistics and Epidemiology). Cambridge: Cambridge University Press; 2011.

33.

Ahmed S, Bartlett SJ, Ernst P, Paré G, Kanter M, Perreault R, Grad R, Taylor L, Tamblyn R. Effect of a web-based chronic disease management system on asthma control and health-related quality of life: study protocol for a randomized controlled trial. Trials. 2011;12:260.

34.

Santana MJ1, Haverman L, Absolom K, Takeuchi E, Feeny D, Grootenhuis M, Velikova G. Training clinicians in how to use patient-reported outcome measures in routine clinical practice. Qual Life Res. 2015;24(7):1707–18 (Epub 2015 Jan 15).

35.

Haywood K, Marshall S, Fitzpatrick R. Patient participation in the consultation process: a structured review of intervention strategies. Patient Educ Couns. 2006;63(1–2):12–23.

36.

Greenhalgh J, Long AF, Flynn R. The use of patient reported outcome measures in routine clinical practice: lack of impact or lack of theory? Soc Sci Med. 2005;60(4):833–43.

Titel: Using PROMs in Healthcare: Who Should Be in the Driving Seat—Policy Makers, Health Professionals, Methodologists or Patients?
verfasst von: Kirstie L. Haywood
Roger Wilson
Sophie Staniszewska
Sam Salek
Publikationsdatum: 01.12.2016
Verlag: Springer International Publishing
Erschienen in: The Patient - Patient-Centered Outcomes Research / Ausgabe 6/2016
Print ISSN: 1178-1653
Elektronische ISSN: 1178-1661
DOI: https://doi.org/10.1007/s40271-016-0197-5

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 6/2016

Patients’ Early Post-Operative Experiences with Lung Transplantation: A Longitudinal Qualitative Study

Factors in Patient Empowerment: A Survey of an Online Patient Research Network

Patients’ Preferences for Genomic Diagnostic Testing in Chronic Lymphocytic Leukaemia: A Discrete Choice Experiment

Translating Evidence to Facilitate Shared Decision Making: Development and Usability of a Consult Decision Aid Prototype

What Do Users of Generic Medicines Think of Them? A Systematic Review of Consumers’ and Patients’ Perceptions of, and Experiences with, Generic Medicines

Treatment Burden and Chronic Illness: Who is at Most Risk?